祥明智能(301226.SZ):實控人之一張敏受讓員工持股平台3.5%股權
格隆匯6月27日丨祥明智能(301226.SZ)公佈,公司收到公司實際控制人之一張敏及公司員工持股平台祥華諮詢通知,獲悉張敏分別與祥華諮詢股東朱慶豐、趙榮朋簽訂了股權轉讓協議,受讓朱慶豐、趙榮朋分別所持祥華諮詢2.5%股權合計22.5萬元註冊資本、1%股權合計9萬元註冊資本;祥華諮詢已於2022年6月27日完成工商變更手續。
該次股權轉讓是祥華諮詢股東之間的股權轉讓,該次股權轉讓完成後,朱慶豐、趙榮朋不再是祥華諮詢的股東,亦不再間接持有公司股份;公司實際控制人之一張敏持有祥華諮詢股權數額由310.5萬元註冊資本增加至342萬元註冊資本,新增31.5萬元註冊資本,祥華諮詢仍為張敏控制企業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.